App-Quantinova.ai

Balloon Pulmonary Angioplasty Improves Clinical Status and Hemodynamics in Patients With Non-operable Chronic Thromboembolic Pulmonary Hypertension in Comparison to Pulmonary Endarterectomy in Operable Patients

Noriaki Emoto - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Lack of Association between Increasing Levels of Hemoglobin A1c and Coronary Atherosclerosis in Non-Diabetic Acute Myocardial Infarction Patients

John A Spertus - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

Very Long-Term (15-23 years) Outcomes of Bare Metal Stenting and Plain Old Balloon Angioplasty

Takeshi Kimura - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Atrial Fibrillation is Associated with Long-Term Incidence of Diabetes

Heidi T May - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Warfarin

Clinical Outcomes of Percutaneous Coronary Intervention (PCI) at Hospital With or Without Onsite Cardiac Surgery Backup in Japan

Seiji Hokimoto - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Ten-Year Clinical Follow-up After Sirolimus-Eluting Stent Implantation

Diego Arroyo - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

sirolimus

The Hypercoagulable Profile of Stent Thrombosis Patients

Thea C Godschalk - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Thrombomodulin alfa

The SYNTAX Score Predicts Major Bleeding after Drug-Eluting Stent implantation in the All-Comers population

Ken Yamazaki - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Tailored Antiplatelet Therapy to Improve Prognosis in Patients Exhibiting Clopidogrel Low-response Prior to Percutaneous Coronary Intervention

Par I. Johansson - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Clopidogrel bisulfate

A Diet Induced Atherosclerosis in LDLR-/- Mice Is Associated With Altered HDL Proteome Dynamics

Ling Li - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Fibrinogen (IV)

Circulating Interleukin-6 and C-Reactive Protein Levels are Related to Platelet Inflammatory Transcripts in the Framingham Heart Study

Eric Mick - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

ILS-969

Impact of Higher On-treatment Platelet Reactivity on Peri-procedural Myocardial Infarction, 1-month and 1-year Clinical Outcomes After Percutaneous Coronary Intervention in a Veteran Population

Mir B Basir - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Clopidogrel bisulfate

Neointimal Appearance of Late Clinical Event related Lesions after Bare-Metal Stent and Sirolimus-Eluting Stent Implantation Assessed by Optical Coherence Tomography

Takashi Kubo - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

sirolimus

KLF5 Contributes to in vivo Thrombus Formation and Cytokine-induced and Tumor-associated Angiogenesis

Satoshi Nishimura - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Impact of Stent Fracture and Stent Recoil on the Incidence and Timing of Stent Thrombosis After Drug-eluting Stent Implantation

Kazushige Kadota - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Long Term Outcomes With Selective Drug Eluting Stent Use in ST-Elevation Myocardial Infarction in an Australian Urban Population

Sujitha Thavapalachandran - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Regional Reduction of Systolic Compacta Thickness Helps to Distinguish Isolated Left Ventricular Non-Compaction From Dilated Cardiomyopathy Using Cardiac Magnetic Resonance Imaging

Wei Chen - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Meta-Analysis of Long Term Outcomes of Intravascular Ultrasound versus Angiographic-Guided Percutaneous Coronary Intervention of Bifurcation Lesions

Kimberly M Brayton - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Libman-Sacks Endocarditis and Cerebrovascular Disease: Role of Microparticles

Alex Schevchuck - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

New Oral Anticoagulants in Patients With Cancer: Evidence From a Meta-analysis of Randomized Trials

Luciano J Pastori - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

rivaroxaban

Filters

7277 Abstracts